Ignite Creation Date:
2024-05-06 @ 9:35 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03011372
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-10
First Post:
2017-01-04
Brief Title:
A Study to Evaluate the Efficacy and Safety of Pemigatinib INCB054828 in Subjects With MyeloidLymphoid Neoplasms With FGFR1 Rearrangement - FIGHT-203
Sponsor:
Incyte Corporation
Organization:
Incyte Corporation